논문 목록
24건 · 최신순- Letter to the editor regarding; Risk of breast implant associated anaplastic large cell lymphoma in a cohort of 3546 women prospectively followed long term after reconstruction with macro-textured breast implants.
- US FDA Safety Communication on Breast Implant Associated Squamous Cell Carcinoma BIA-SCC).
- Commentary on: Aesthetic Surgery Journal Articles on Injectable Weight Loss Medications and Their Role in Plastic Surgery.
-
Gel Cohesivity and Breast Augmentation: Applications to Clinical Practice.
Matching breast implant gel cohesivity to the patient's needs based on anatomical and soft-tissue considerations and patient preferences is essential to optimizing aesthetic outcomes and patient satisfaction. Generally, gel cohesivity contr…
-
In Vitro Evaluation of Common Antimicrobial Solutions Used for Breast Implant Soaking and Breast Pocket Irrigation-Part 1: Efficacy Against Planktonic Bacteria.
[BACKGROUND] Planktonic bacteria can be inadvertently introduced during breast surgery procedures, which are hypothesized to lead to complications such as infection, capsular contracture, breast implant-associated anaplastic large cell lymp…
- Commentary on: Three-Dimensional Evaluation of the Depressor Anguli Oris and Depressor Labii Inferioris for Botulinum Toxin Injections.
- Breast Implant-Associated Illness: Medicine by Belief, So Says Dr. Google.
-
Implant Surface Options and Biofilm Mitigation Strategies.
Two important topics in breast augmentation and reconstruction relate to device surface texture and practices to mitigate biofilm contamination of implants. Breast augmentation can be considered a manufacturing process where planning concep…
-
Lactation Outcomes in More Than 3500 Women Following Primary Augmentation: 5-Year Data From the Breast Implant Follow-Up Study.
[BACKGROUND] Women with breast implants may have concerns about their ability to successfully breast-feed. The Breast Implant Follow-up Study (BIFS-001) is a large, 10-year observational study evaluating the performance and safety of Natrel…
-
Betadine and Breast Implants.
In the fourth quarter of 2017, the US FDA reviewed and approved a request by one of the breast implant manufacturers for a change in the Directions for Use (DFU) that removed warnings regarding the use of Betadine (povidone-iodine [PI] 10% …
-
Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants.
[BACKGROUND] Bacteria/biofilm on breast implant surfaces has been implicated in capsular contracture and breast implant-associated anaplastic large-cell lymphoma (ALCL). Macrotextured breast implants have been shown to harbor more bacteria …
-
Low Risk of Skin and Nipple Sensitivity and Lactation Issues After Primary Breast Augmentation with Form-Stable Silicone Implants: Follow-Up in 4927 Subjects.
[BACKGROUND] Natrelle 410 implants (Allergan, Inc., Irvine, CA) are approved in the United States for breast augmentation, reconstruction, and revision. [OBJECTIVES] To assess the risk of nipple and skin sensation changes and lactation iss…
-
Clinical application of a silk fibroin protein biologic scaffold for abdominal wall fascial reinforcement.
[BACKGROUND] Preclinical studies have demonstrated that macroporous silk fibroin protein scaffolds are capable of promoting physiologically durable supportive tissue, which favors application of these engineered tissues for clinical implant…
-
Clinical trial outcomes of high- and extra high-profile breast implants.
[BACKGROUND] Clinical data concerning potential risks and benefits associated with the use of high- and extra high-profile breast implants are lacking. [OBJECTIVES] The authors assess the risk of adverse events (AE) with high- and extra hi…
-
Evaluation of a novel high-intensity focused ultrasound device for ablating subcutaneous adipose tissue for noninvasive body contouring: safety studies in human volunteers.
[BACKGROUND] High-intensity focused ultrasound (HIFU) is an energy-based medical technology with many clinical applications. A device under clinical investigation in the United States (LipoSonix; Medicis Technologies Corporation, Bothell, W…
- Patient safety at 10 years.
-
Noninvasive body sculpting technologies with an emphasis on high-intensity focused ultrasound.
[BACKGROUND] Body-sculpting procedures are becoming increasingly popular in the United States. Although surgical lipoplasty remains the most common body sculpting procedure, a demand exists for noninvasive alternatives capable of reducing f…
-
A comparison of outcomes involving highly cohesive, form-stable breast implants from two manufacturers in patients undergoing primary breast augmentation.
[BACKGROUND] Although there have been reports of single-surgeon outcomes with highly cohesive, form-stable silicone gel implants in women undergoing primary breast augmentation, there has been only one study published that compares the outc…
-
Risks and opportunities for plastic surgeons in a widening cosmetic medicine market: future demand, consumer preferences, and trends in practitioners' services.
[BACKGROUND] The American Society of Plastic Surgeons and the American Society for Aesthetic Plastic Surgery launched a joint Cosmetic Medicine Task Force to address the growing trend of non-plastic surgeons entering the cosmetic medicine f…
- Breast augmentation roundtable.
- Teenage breast augmentation: validating outcome data and statistics in plastic surgery.
-
Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants.
During the U.S. Food and Drug Administration's advisory panel hearings to evaluate the premarket approval for conventional silicone gel implants on October 14 and 15, 2003, panel members and patient advocate representatives focused on four …
- David Weaver Robinson, M.D., 1914 to 2003.
- Lost in the rush hour on the information superhighway.